Items tagged with “copaxone”
-
Basic Science Research and Multiple Sclerosis
2009-09-19T18:01:43-04:00
Basic research can not only lead scientists in unexpected directions, but can have unanticipated positive impacts. One Weizmann Institute of Science research success story features the multiple sclerosis (MS) drugs Copax...
-
Israeli Scientists Identify Genes That Affect Responses of Multiple Sclerosis Patients to Copaxone®
2007-10-10T13:23:00-04:00
REHOVOT, ISRAEL—October 10, 2007—A group of Israeli scientists from the Technion — Israel Institute of Technology, the Weizmann Institute of Science, and Teva Pharmaceutical Industries have recently ...
-
T Cells for Brain Cells: Can Autoimmunity Fend Off Neurodegeneration?
2006-01-02T07:06:00-04:00
In 2002 a clinical trial of an experimental Alzheimer's vaccine was halted when a few patients began experiencing brain inflammation, a result of the immune system mounting an attack against the body. Now some researchers ...
-
Battling Glaucoma
2002-12-02T10:15:00-04:00
One in every hundred adults in the Western world suffers from chronic glaucoma, a disease that causes blindness. In most cases the disease results from increased pressure inside the eye, caused by defective drainage of the...
-
Weizmann Institute Scientists Block Loss of Eyesight in Animals With a Glaucoma-like Disease
2001-03-06T10:29:00-04:00
Rehovot, Israel—March 6, 2001—Weizmann Institute scientists have succeeded in stopping the progressive loss of eyesight in animals with a glaucoma-like disease. Their innovative study, reported in the ...